The researcher warned that AI leaders sincerely believe the technology could kill all of humanity by the decade’s end, saying it’s not a ’marketing stunt.’ ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Alarm grew after a researcher resigned, warning that the “people building AI earnestly believe that it could kill us all by ...

'We really do earnestly believe AI could kill all humans!' ...

Alphabet demonstrates prodigious Google Cloud growth, with quarterly revenue surging from $20B to $25B in just one quarter.

View the basic RXRX option chain and compare options of Recursion Pharmaceuticals, Inc. on Yahoo Finance.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...